Market Tracker

01/30 6:05pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

19.15
Data as of Jan 30
 +0.57 / +3.07%
Today’s Change
5.40
Today|||52-Week Range
25.60
+19.39%
Year-to-Date

Today’s Trading

Previous close18.58
Today’s open18.45
Day’s range18.39 - 19.68
Volume1,338,639
Average volume (3 months)944,848
Market cap$903.1M
Dividend yield--
Data as of 3:59pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)+76.89%
Earnings growth (this year)-100.83%
Earnings growth (next 5 years)--
Revenue growth (last year)+54.09%
P/E ratioNM
Price/Sales14.53
Price/Book8.31

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+0.15+0.48%
ZIOPZIOPHARM Oncology In...-0.13-1.43%
ZSPHZS Pharma Inc-0.90-1.96%
KPTIKaryopharm Therapeut...-0.30-1.12%
Data as of 4:14pm ET, 01/30/2015

Financials

Next reporting dateFebruary 26, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$19.6M
Annual profit (last year)-$18.7M
Net profit margin-95.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts